Clinical Trial Update: Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing minus anthracycline or short-term vs epirubicin and cyclophosphamide followed by paclitaxel for adjuvant therapy in primary breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Primary Breast Cancer | Phase 3 | Status: COMPLETED